John Markels - Jun 3, 2022 Form 4 Insider Report for SANGAMO THERAPEUTICS, INC (SGMO)

Role: Director
Signature: John Markels, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol: SGMO
Transactions as of: Jun 3, 2022
Transactions value $: $25,029
Form type: 4
Date filed: 6/6/2022, 04:41 PM
Previous filing: Mar 1, 2022
Next filing: Dec 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGMO	Common Stock	Purchase	$25K	+6.78K	+26.4%	$3.69	32.5K	Jun 3, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (a) 1,667 shares subject to the Reporting Person's February 11, 2020 restricted stock unit ("RSU") grant that will vest in one final annual installment on February 11, 2023 and (b) 12,500 shares subject to the Reporting Person's February 25, 2022 RSU grant that will fully vest in one installment on February 25, 2023. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through each such date and subject to acceleration as provided in the 2018 EIP.

Content

Includes (a) 1,667 shares subject to the Reporting Person's February 11, 2020 restricted stock unit ("RSU") grant that will vest in one final annual installment on February 11, 2023 and (b) 12,500 shares subject to the Reporting Person's February 25, 2022 RSU grant that will fully vest in one installment on February 25, 2023. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through each such date and subject to acceleration as provided in the 2018 EIP.